Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O. V. Logvinova"'
Autor:
P. I. Kuznetsova, T. I. Romantsova, O. V. Logvinova, E. S. Tsvetkova, E. I. Kremneva, E. A. Troshina, M. M. Tanashyan
Publikováno v:
Ожирение и метаболизм, Vol 19, Iss 1, Pp 74-82 (2022)
AIMS. Study of the dynamics of brain activity using functional MRI (fMRI) in obese patients treated with sibutramine (Reduxine®).MATERIALS AND METHODS. The study enrolled patients with a body mass index (BMI) ≥30 kg/m2 . All participants underwent
Externí odkaz:
https://doaj.org/article/945ee79662bc43b4972fa5ada1990e7a
Autor:
O. V. Logvinova, E. A. Troshina
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 156-164 (2021)
Introduction. One of the objectives of weight loss in obesity is to prevent metabolic disorders associated with it. An important component in the maintenance of the achieved results is a change of eating behavior.Goal: to study the effect of liraglut
Externí odkaz:
https://doaj.org/article/f64d232cd0724d37bcb5ae95112eb411
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 58-62 (2017)
Obesity is a chronic disease associated with cardiometabolic risk factors of cardiovascular diseases and type 2 diabetes. In 2016, in Russia a new drug was registered for the treatment of patients with adiposity - liraglutide 3.0 mg, which is an anal
Externí odkaz:
https://doaj.org/article/38afe9d4458d4d0eb4308f104c3e80dc
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 4, Pp 535-539 (2016)
This article provides our own clinical observation of the patient with multiple endocrine neoplasia type 2B (MEN2B) associated with a germinal mutation in the RET proto-oncogene. Although there are highly informative laboratory methods available, in
Externí odkaz:
https://doaj.org/article/e32fa037f0a4481bae88bda500114e2d
Autor:
P. I. Kuznetsova, T. I. Romantsova, O. V. Logvinova, E. S. Tsvetkova, E. I. Kremneva, E. A. Troshina, M. M. Tanashyan
Publikováno v:
Obesity and metabolism. 19:74-82
AIMS. Study of the dynamics of brain activity using functional MRI (fMRI) in obese patients treated with sibutramine (Reduxine®).MATERIALS AND METHODS. The study enrolled patients with a body mass index (BMI) ≥30 kg/m2 . All participants underwent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a55bb7663d1e0765ff50fc59ff1848d
https://doi.org/10.14341/omet12810
https://doi.org/10.14341/omet12810
Publikováno v:
Problemy endokrinologii. 68(3)
BACKGROUND: The COVID-19 pandemic has accelerated the development of telemedicine technologies. Today there is evidence of the successful use of telemedicine in various fields of health care, in particular in endocrinology. At the same time, there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c15360f0eaba802c77f5997bf5261d
https://pubmed.ncbi.nlm.nih.gov/35841163
https://pubmed.ncbi.nlm.nih.gov/35841163